DOV-216,303
Overview[edit]
DOV-216,303 is a triple reuptake inhibitor that affects the neurotransmitter systems of serotonin, norepinephrine, and dopamine. It is primarily studied for its potential use in the treatment of major depressive disorder and other psychiatric disorders.
Mechanism of Action[edit]
DOV-216,303 functions by inhibiting the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine. This action increases the availability of these neurotransmitters in the synaptic cleft, which is believed to contribute to its antidepressant effects.
Serotonin Reuptake Inhibition[edit]
Serotonin is a neurotransmitter that plays a crucial role in mood regulation. By inhibiting its reuptake, DOV-216,303 increases serotonin levels, which can help alleviate symptoms of depression.
Norepinephrine Reuptake Inhibition[edit]
Norepinephrine is involved in alertness and energy. DOV-216,303's inhibition of norepinephrine reuptake can enhance these effects, potentially improving mood and cognitive function.
Dopamine Reuptake Inhibition[edit]
Dopamine is associated with pleasure and reward. By preventing its reuptake, DOV-216,303 may enhance motivation and pleasure, which are often diminished in depressive states.
Clinical Development[edit]
DOV-216,303 has been investigated in various clinical trials to assess its efficacy and safety in treating depression. The compound's ability to target three neurotransmitter systems simultaneously distinguishes it from traditional selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
Potential Benefits[edit]
The triple reuptake inhibition mechanism of DOV-216,303 may offer advantages over existing antidepressants by providing a more comprehensive approach to neurotransmitter modulation. This could result in improved efficacy for patients who do not respond to conventional treatments.
Side Effects[edit]
As with many psychotropic medications, DOV-216,303 may have side effects, including but not limited to insomnia, nausea, and headache. The safety profile of DOV-216,303 continues to be evaluated in ongoing research.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
